NCATS | Technology Transfer

Novel inhibitors of protein kinase signaling that are neuroprotective and have potential applicability for the treatment of glaucoma, optic nerve disease, and other forms of neurodegeneration

Read more about Novel inhibitors of protein kinase signaling that are neuroprotective and have potential applicability for the treatment of glaucoma, optic nerve disease, and other forms of neurodegeneration

US Application 61/443,035
Filed on 2011-02-15

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives As Potent And Selective Inhibitors Of Human 12-Lipoxygenase.

Read more about 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives As Potent And Selective Inhibitors Of Human 12-Lipoxygenase.

US Application 61/889,396
Filed on 2013-10-10

Method of Blocking Transmission of Malarial Parasite

Read more about Method of Blocking Transmission of Malarial Parasite

US Application 61/904,884
Filed on 2013-11-15

Method For Identifying And Identification Of Small Molecule Inhibitors Of SIX/EYA Interaction For The Treatment Of Cancers

Read more about Method For Identifying And Identification Of Small Molecule Inhibitors Of SIX/EYA Interaction For The Treatment Of Cancers

US Application 61/718,682
Filed on 2012-10-25

Use of Epoxyketone Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

Read more about Use of Epoxyketone Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

US Application 61/702,297
Filed on 2012-09-18

The Use of Boronate Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

Read more about The Use of Boronate Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

US Application 61/702,295
Filed on 2012-09-18

A new chemical entity useful for treating various diseases

Read more about A new chemical entity useful for treating various diseases

US Application 61/710,505
Filed on 2012-10-05

Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

Read more about Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

US Application 61/801,784
Filed on 2013-03-15

Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

Read more about Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

US Application 61/802,393
Filed on 2013-03-16

Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

Read more about Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

US Application 61/802,217
Filed on 2013-03-15

Subscribe to NCATS